Menu Back toSpeakers

Medical Affairs and Scientific Communications Forum

Medical Communication, MSL, and Medical Writing.


  • Kevin  Appareti, MBA

    Kevin Appareti, MBA

    • Senior Director, Global Medical Science Liaison
    • Philips HealthTech, United States

    Kevin Appareti is Senior Director, Global Medical Science Liaison for the Office of Medical Affairs at Royal Philips. He leads the Key Thought Leadership Program within the Cheif Medical Office and works across Philips’ businesses and markets to build strong internal and external relationships with key thought leaders and influencers. Kevin holds a bachelor’s degree in physical science from Colorado State University and an MBA from Boston University and has been an adjunct professor at the University of Massachusetts at Lowell, Manning School of Business.

  • Anne  Arvizu, PharmD

    Anne Arvizu, PharmD

    • CEO & Medical Affairs Advisor
    • RxER Communications, United States

    Anne is founder and CEO of RxER Communications Corp ( With 20 years of progressive leadership in the pharma/biotech industry, she has served in key roles, such as, Global Head of Medical Information for Baxter, Global Head of Medical Information, Literature Services/ Knowledge Management, Baxalta, Member Executive, PhactMI, and Regional Head of Medical Information & Medical Communications for GlaxoSmithKline, LATAM. As a seasoned C-suite consultant, she currently engages biotech clients with Medical Information department build, launch and scale. She is an advocate for community health and wellness and also serves as Vice Chair, South Florida YMCA Board of Directors.

  • J. Lynn  Bass, PharmD

    J. Lynn Bass, PharmD

    • Director, Medical Science Liaisons, Americas
    • Santen, Inc., United States

    Lynn has over 19 years of experience in Medical Science Liaison and Medical Affairs roles across the pharmaceutical industry. She is currently the Director, MSLs (Americas) at Santen, Incorporated. Previously, Lynn worked in management and individual contributor MSL roles at Jazz Pharma, Baxter/ Baxalta, Amgen, and Lilly. Lynn has authored/ co-authored several MSL surveys and is the elected Chair, MSL Community at the Drug Information Association (DIA).

  • Peter  Baumeister, PhD

    Peter Baumeister, PhD

    • Senior Manager, Global Scientific Communications
    • Amgen Inc., United States

    Peter is currently a senior manager and the lead for Strategy and Operations, Global Scientific Communications at Amgen, Inc. He has led projects that have developed innovative solutions for all aspects of medical communications and scientific exchange. He received his PhD in Molecular Biology and Biochemistry from USC and lives in Thousand Oaks, CA, where he enjoys skateboarding, surfing, and watching his 3 kids fail and succeed over and over again.

  • Poonam A. Bordoloi, PharmD

    Poonam A. Bordoloi, PharmD

    • Associate Director, Strategic Medical Communications and Innovation
    • Celgene Corporation, United States

    Prior to joining Celgene, Poonam worked at Sanofi MI for 12 years. She is actively involved with DIA, is a DIA planning board member, and continues to chair and speak at meetings. She has over 22 years of experience in the Medical Information setting and has 2 publications regarding Social Media and Medical Information Trends. Prior to Sanofi, Poonam worked in the Global Competitive Intelligence group with Johnson and Johnson and in the Medical Information Department at Parke-Davis. She also has experience in managed care with her work as a Formulary Director at a Pharmacy Benefits Management Company. Poonam graduated from Rutgers College of Pharmacy and completed her PharmD from Shenandoah University.

  • David  Bowers, PharmD

    David Bowers, PharmD

    • Director, Medical Communications
    • PPD, United States

    David has 15+ years of experience managing pharmaceutical contact center programs at PPD. He supports global medical information for pharmaceutical, biotechnology and medical device clients. He has a background in pharmacy, with a Doctorate of Pharmacy from the University of North Carolina in the United States. During his time at PPD, David has worked with over 30 client contact center programs providing medical information, pharmacovigilance and product complaint processing, patient adherence programs, REMS support and other services. Including implementing contact center operations in the US, Europe, Mexico and Brazil. David has successfully implemented numerous telephony systems and contact center databases.

  • Kathryn  Bucci

    Kathryn Bucci

    • Medical Governance Lead
    • Pfizer, Inc., United States

    B.S.Pharm and PharmD, St. John’s University; Residency in Hospital Pharmacy Practice, Medical College of Virginia Hospitals; Fellowship in Clinical Pharmacy Practice in Family Medicine, Medical University of South Carolina. Faculty, Department of Community and Family Medicine, Duke University Medical Center, Department of Pharmacy Practice, Campbell University (dual appointment). Faculty, Department of Family Medicine, Department of Pharmacy Practice, Medical University of South Carolina. Medical Outcomes Specialist, Pfizer Inc (2000-2015); Medical Governance Lead, 2015-present . Board Certified Pharmacotherapy Specialist. Fellow, American Society of Health-System Pharmacists.

  • Stephanie L. Byrdé, BSN, MS, RN

    Stephanie L. Byrdé, BSN, MS, RN

    • Manager, Clinical Pharmacology Scientific Communications
    • Eli Lilly & Company, United States

    Stephanie Byrdé has a Bachelor's degree in Nursing from Indiana University, and a Master of Leadership Development from Saint Mary-of-the-Woods College. She has worked in the Scientific Communications function at Eli Lilly and Company as a team leader and manager of various therapeutic areas for over 13 years. Most recently, Stephanie has worked as the Clinical Pharmacology Manager for Scientific Communications at Lilly.

  • Ivy Lee Chang, PharmD

    Ivy Lee Chang, PharmD

    • Associate Director, Medical Communications
    • Genentech, Inc., A Member of the Roche Group, United States

    Ivy has 16+ years of experience in the pharmaceutical industry. She is an Associate Director in Medical Communications at Genentech where she has oversight of products in rheumatology and immunologic diseases. Prior to joining Genentech, she was a Clinical Pharmacist in General Surgery, Surgical Subspecialties, and Solid Organ Transplant at the University of California San Francisco (UCSF) Medical Center, and an Assistant Clinical Professor with the UCSF School of Pharmacy. Ivy Chang received her Doctor of Pharmacy degree from the University of Tennessee in Memphis and completed a residency in Pharmacy Practice at UCSF.

  • Michael  Church, MA

    Michael Church, MA

    • Senior Director, Medical Writing
    • Inventiv Health, United States

    Currently Senior Director of Medical Writing for inVentiv Health Clinical, Michael has 15 years of industry experience and oversees one of the largest medical writing FSPs in the country, which includes teams of regulatory and commercialization writers, editors, and regulatory publishers. This is his second year on the planning committee for the DIA scentific communications annual meeting.

  • David B. Clemow, PhD

    David B. Clemow, PhD

    • Advisor, Scientific Communications Information Strategy
    • Eli Lilly and Company, United States

    David is an Advisor Scientific Communications at Eli Lilly with over 20 years of regulatory, publication, and promotional scientific communications experience in the pharmaceutical industry. His work has included document authoring, team management, operations consulting, clinical research, and medical affairs. David is Chair of DIA’s Medical Writing Community and Community Leadership Council, as well as the American Medical Writers Association Certification Commission.

  • Rebecca  Falcone, PharmD

    Rebecca Falcone, PharmD

    • Global Medical Information Systems Lead, GMI Operations
    • Sanofi, United States

    Rebecca Falcone, PharmD is a Senior Manager in the Medical Information department at Sanofi where she provides medical information support for the Oncology/Hematology/Transplant products and manages the medical slide system for use by the Field Medical and Medical Information teams. She has over 17 years of pharmaceutical industry experience. Rebecca was a Core Curriculum faculty member at the DIA Medical Affairs and Scientific Communications Forum (MASC) for 3 years. She has also been a speaker at sessions for both the DIA Annual and MASC meetings.

  • Maureen  Feeney, PharmD, MBA, RPh

    Maureen Feeney, PharmD, MBA, RPh

    • Head Global Medical Information
    • Shire Pharmaceuticals, United States

    Dr. Feeney has over 16 years of experience in Medical Affairs, including leadership roles in Medical Information and Medical Communications. She is currently the Head of Global Medical Information at Shire. Prior to joining Shire, Dr. Feeney led the development and implementation of a new Medical Information Department and Call Center, at Incyte. She held various positions of increasing responsibility including, Director of Medical Information at GlaxoSmithKline. Prior to joining industry, Dr. Feeney was a Clinical Pharmacist at Thomas Jefferson University Hospital in Philadelphia, PA. In addition, she has served as Adjunct Faculty at the University of the Sciences in Philadelphia, as an Instructor in Pharmacy Practice.

  • Eileen  Girten, MS

    Eileen Girten, MS

    • Principal Medical Writer, Clinical Division
    • INC Research/inVentiv Health, United States

    Eileen M. Girten, MS, is a Principal Medical Writer with inVentiv Health where she writes regulatory and publications deliverables and mentors writers. Eileen earned a BA in Chemistry from Rosemont College, an MS in Psychology from Saint Joseph’s University, and an MS in Biomedical Writing from the University of the Sciences in Philadelphia. She is an Adjunct Assistant Professor in Biomedical Writing at the University of the Sciences and currently serves as the Medical Writing Track Co-chair of the 2017 Medical and Scientific Communications Annual Forum. Eileen also has previously served as the Chair of the DIA Medical Writing Community, Education Committee and has served as a Training Instructor for DIA.

  • Kathleen M Guindon, PhD, MS, RN

    Kathleen M Guindon, PhD, MS, RN

    • Director, Clinical Science Liaison
    • Puma Biotechnology, United States

    Kathleen is responsible for one or multiple clinical studies, interacts with all members of the clinical research and development team as well as key opinion leaders, and supervises other Clinical Science personnel providing support to assigned projects. She is a qualified registered nurse and holds the a Master’s from State University of New York at Buffalo in Oncology Clinical Nurse Specialist, and a doctoral degree from the University of Phoenix in Management and Organizational Leadership. Her dissertation focused on front line management experience to the post acquisition organizational setting. She has authored several peer reviewed publications in Oncology nursing.

  • Jennie G. Jacobson, PhD

    Jennie G. Jacobson, PhD

    • Consultant, Scientific Communications
    • Eli Lilly and Company, United States

    Jennie G. Jacobson works for Eli Lilly and Company, where she writes about their wide range of therapies for diabetes and is active in process improvement. In her 17 years as a medical writer, she has written about infectious disease, mental health, health outcomes research, and diabetes. What Jennie loves most about being a medical writer is the ongoing opportunities to learn new things. She earned her BA at Swarthmore College, her PhD at Harvard University, and her Certificate in Medical Writing at the University of Chicago. She lives in the Philadelphia area with her family.

  • Darryl Zachary L'Heureux, PhD, MPharm, MSc

    Darryl Zachary L'Heureux, PhD, MPharm, MSc

    • Medical Writing Manager
    • Bristol-Myers Squibb, United States

    As a member of both the DIA and AMWA, Dr. L’Heureux serves as a conference chair, present lectures and leads roundtables at professional and educational events. He received his PhD in Cancer Biology and Masters in Pharmacy, Quality Assurance and Regulatory Affairs from Temple University in Philadelphia, PA. Upon graduation, he continued his research in cancer biology and clinical oncology working across the cooperative group structure of the NCI. He has consulted with academic partnerships to develop biomarkers for diagnosis, prognosis, and disease surveillance. Working across the range of small biotech to large pharmaceutical companies, Dr. L’Heureux has returned to his early research interest in immuno-oncology and tumor biology.

  • Jeff  Mathews, MPH

    Jeff Mathews, MPH

    • Director, Medical Information
    • Gilead Sciences, United States

    Jeff is the Director of US Medical Information at Gilead Sciences, where he is responsibility for developing and executing strategies to deliver medical information services across all Gilead products in the US. He has nearly 14 years of Medical Communications experience with roles in Scientific Communications, Publication Planning, and Medical Information at Eli Lilly, Sunovion Pharmaceuticals, and Vertex Pharmaceuticals. He holds a Masters of Public Health in Epidemiology from Indiana University and is a Certified Medical Publication Professional (CMPP).

  • David  Meats

    David Meats

    • Principal Medical Writer
    • inVentiv Health Clinical, United States

    David Meats is a cellular and developmental biologist working as a Principal Medical Writer for a major CRO. David has 17 years of experience as a regulatory and scientific writer for both device and pharmaceutical submissions. David has recently championed the development of processes and tools for clinical trial lay summaries with a number of clients.

  • Robert  Paarlberg, MS

    Robert Paarlberg, MS

    • Principal
    • Paarlberg & Associates LLC, United States

    Robert Paarlberg is the Principal of Paarlberg & Associates LLC, a consultancy specializing in global clinical trial disclosure and regulatory policy/intelligence. Bob is also current Chair of DIA’s Clinical Trial Disclosure Community. Bob has more than 35 years of pharmaceutical industry experience with the vast majority of his experience in US and international regulatory affairs.

  • David A. Price, PhD

    David A. Price, PhD

    • Consultant - Field Medical Strategy and Capabilities Consultant
    • Lilly USA, LLC, United States

    David has served as Medical Liaison supporting multiple therapeutic areas, including: Psychiatry, Urology and Musculoskeletal. In these roles, David developed and maintained TL relationships in the Midwest/Great Plains and Southwest/Mountain regions. In 2014, David joined Lilly’s Field Medical Operations team providing Strategy & Capabilities support for the US Medical Liaisons. David currently is a Consultant – Field Medical Excellence for Lilly’s US BioMedicines Medical Liaison teams. Prior to joining Lilly, David completed a NIA-funded fellowship on neurosurgical devices at the University of Kentucky Medical Center and a NIDA-funded fellowship on drug addiction at the University of Colorado School of Medicine.

  • Robin  Whitsell

    Robin Whitsell

    • President
    • Whitsell Innovations, Inc., United States

    Founder and president of Whitsell Innovations (WI), Inc., a medical writing firm headquartered in Chapel Hill, NC with employees in 13 states. She has 20 years experience, specializing in medical writing and regulatory submission strategies for the life sciences. Prior to founding WI, Ms. Whitsell was the assistant director of preclinical & clinical development at Inspire Pharmaceuticals, a team lead at GlaxoWellcome (now GlaxoSmithKline), and a CRA at Parexel International. Ms. Whitsell served on the boards of the Diversity Alliance for Science and the Healthcare Businesswomen’s Association. She has degrees in biophysics and physics from Miami University in Oxford, OH, and interned at Los Alamos National Laboratory.

  • Robin L. Winter-Sperry, DrMed, MD

    Robin L. Winter-Sperry, DrMed, MD

    • Head, Global Field Based Medical Excellence
    • Sanofi Genzyme, United States

    Dr. Robin Winter-Sperry started working in the industry in the area of Dermatology. She has had a long and distinguished career including Sanofi/Genzyme Global Medical Affairs, Strategy & Tactics in the area of Multiple Sclerosis and President and CEO of Scientific Advantage, LLC. She created Novartis’ MSL department of Scientific Operations and Sanofi-Synthelabo’s Medical Therapeutic Liaison division. She has pioneered the recognition of MSLs as a specialty in the biopharmaceutical and device industry and is responsible for creating and developing many of the industry’s leading Medical Affairs and Medical Liaison teams.

  • Ann M Winter-Vann, PhD

    Ann M Winter-Vann, PhD

    • Senior Medical Writer and Consultant
    • Whitsell Innovations, Inc., United States

    Ann Winter-Vann earned her PhD in Molecular Cancer Biology from Duke University, where she was a predoctoral fellow of the Howard Hughes Medical Institute. Following a postdoctoral position in the Pharmacology Department at UNC-Chapel Hill, Ann joined Whitsell Innovations, Inc. as a medical writer. She has extensive experience in clinical regulatory writing, and also provides consultations and training in medical writing. Since 2008, Ann has co-taught a science writing course for first-year biomedical graduate students at UNC-Chapel Hill. Ann is a past president of the Carolinas chapter and is on the national Board of Directors for the American Medical Writers Association (AMWA).

  • Pamela  Cyrus, MD

    Pamela Cyrus, MD

    • Vice President and Head of Medical Governance, Pharmaceuticals
    • Bayer Healthcare Pharmaceuticals, Inc., United States

  • Paul  Grant

    Paul Grant

    • Healthcare Engagement Strategist
    • United Kingdom

    Paul Grant has been involved in digital media since the inception of the public Internet. For much of the past 11 years, he has been based in London U.K., where he produced digital engagement strategies and social media insights for the leading health and pharmaceutical organizations in the world. Until his return to Australia, he was faculty lecturer in social media for the European Center of Pharmaceutical Medicine, an advisor in pharmaceutical guidance for digital communications, and Chief Innovation Officer for a global health consultancy. Paul is passionate about inspiring and motivating organizations towards an empowered and sustainable future capability.

  • Craig J. Klinger, RPh

    Craig J. Klinger, RPh

    • Consultant, Field Medical Liaison Strategy and Capabilities - Trainer
    • Lilly USA, LLC, United States

    Craig has been an employee of Eli Lilly and Company for the past 25 years. Craig was a Senior Medical Liaison Consultant in the New York City Metropolitan area for over 13 years. He currently is the USMD Trainer for all on boarding MLs at Lilly.

  • Representative Invited

    Representative Invited

    • GRIFOLS Inc., United States
  • Ed  Cunningham, PharmD

    Ed Cunningham, PharmD

    • Director, Medical Science Liaison Lead
    • Sunovion Pharmaceuticals Inc., United States

    Ed Cunningham, PharmD is Senior Director and Neurology Medical Science Liaison (MSL) Lead at Sunovion Pharmaceuticals Inc. Ed is based in Milwaukee, WI, and is responsible for overseeing the US Neurology MSL team. Prior to joining Sunovion, Ed was the Director of Specialty Care MSLs at Eisai Inc., leading the company’s Neuroscience and Metabolic MSL teams. Ed obtained his PharmD degree from Philadelphia College of Pharmacy and completed a 1-year Drug Information Residency with Janssen Pharmaceutica. Ed has been in the pharmaceutical industry for 14 years, working in a variety of Medical Affairs functions, including Medical Information, Medical Education, Investigator Initiated Studies, and MSLs.

  • Rebecca A. Vermeulen, RPh

    Rebecca A. Vermeulen, RPh

    • Head, Customer Strategy Global Medical Affairs
    • Hoffmann-La Roche Ltd., Switzerland

    Rebecca brings a variety of experiences and capabilities to her role as Global Customer Strategy for Global Medical Affairs at Roche. She has spent 25 years in the pharmaceutical industry leading teams across Medical Affairs including Medical Communications and MSLs. Rebecca has has been responsible for creating global standards for information exchange with healthcare professionals. Rebecca is currently on the Global Board of Directors for the DIA.

  • Jim R. Wilkinson, PhD

    Jim R. Wilkinson, PhD

    • Executive Director, Hem-Onc Regional Medical Liaisons, Global Scient
    • Amgen, Inc., United States

    Jim Wilkinson, Ph.D. is the Executive Director and TA Head for the Hematology-Oncology Regional Medical Liaisons (MSLs) at Amgen. Accountabilities include managing the overall field-based strategy for marketed/pipeline products, creating strategic scientific engagement plans for opinion leaders (OLs), OL identification and engagement, disease state and product discussions, clinical research support, scientific congresses, and formulary support. At Amgen for over 14 years now, Jim previously managed the Medical Communications Department responsible for global publication planning, congresses, scientific advisory boards, creation of MSL resources, and promotional review committee (PRC) participation across several therapeutic areas.

  • Alicia Alexander Cadogan, PharmD, RPh

    Alicia Alexander Cadogan, PharmD, RPh

    • Director, Oncology Medical Information
    • Pfizer, Inc., United States

    Alicia is the Director, North America Team Lead, and Global Therapy Area Lead for Medical Information at Pfizer Inc. Alicia has served as Chair of both the Core Curriculum and the Medical Communications Workshop (now known as the Medical Affairs and Scientific Communications Forum). Alicia received her BS from St. John’s University, and her PharmD from Albany College of Pharmacy. After a fellowship in Nephrology and 2 years as Assistant Professor at the University of Pittsburgh School of Pharmacy, Alicia spent 6 years in Medial Communications at Wyeth Pharmaceuticals, and 5 years as a Medical Director at CoMed Communications.

  • Paul  Berg, MS

    Paul Berg, MS

    • Principal Research Scientist
    • Eli Lilly & Company, United States

  • David H Brown, MA, MSc

    David H Brown, MA, MSc

    • Associate Director, Medical Communications Science
    • AstraZeneca Pharmaceuticals LP, United States

    David Brown manages regulatory medical writers involved in CTD production and is involved in development of company best practice. He has 17 years of experience in regulatory medical writing and is a graduate of Oxford and Sheffield Universities in the UK.

  • Michelle  Clausen, PharmD, RPh

    Michelle Clausen, PharmD, RPh

    • Senior Director, Chief Medical Office- Strategy & Innovation Team
    • Pfizer, Inc., United States

  • Deborah E. Collyar

    Deborah E. Collyar

    • President
    • Patient Advocates In Research (PAIR), United States

    Deborah Collyar is a leader in health advocacy, utilizing successful business, leadership and IT skills to bridge gaps between science, research, medicine and patients. Her advocacy work encompasses diseases, programs and policies at grassroots, national and international levels. She regularly advises organizations, institutions, universities, cancer centers, non-profits, government agencies, companies, and most importantly, patients. Deborah and her husband have survived 3+ cancers.

  • Evelyn R. Hermes-DeSantis, PharmD

    Evelyn R. Hermes-DeSantis, PharmD

    • Clinical Professor, Ernest Mario School of Pharmacy
    • Rutgers, The State University of New Jersey, United States

    Evelyn Hermes-DeSantis, PharmD, BCPS, is a Clinical Professor at the Ernest Mario School of Pharmacy, Rutgers, the State University of New Jersey and is the Director of Drug Information Services at Robert Wood Johnson University Hospital. She received her undergraduate and graduate degrees from Rutgers. After completing a Specialized Residency in Drug Information at the Medical College of Virginia Hospital, she practiced at the University of Utah Hospital before returning to Rutgers. Over the years she has trained over 25 Specialized Residents in Drug Information and has precepted numerous Residents and Industry Fellows.

  • Darren  Taichman

    Darren Taichman

    • Executive Deputy Editor
    • Annals of Internal Medicine, United States

  • Mark  Barnes

    Mark Barnes

    • Partner
    • Ropes & Gray, LLP, United States

  • Elizabeth  Blalock

    Elizabeth Blalock

    • Managing Editor, Journal of Investigative Dermatology
    • Society for Investigative Dermatology, United States

  • TK  Booker Porter

    TK Booker Porter

    • Senior Manager Global Regulatory Writing, Protocol Authoring Lead
    • Amgen, Inc., United States

  • Michelle  Drozd

    Michelle Drozd

    • Deputy Vice President, Policy & Research
    • Pharmaceutical Research and Manufacturers of America (PhRMA), United States

  • Joyce P. Fairclough, PharmD

    Joyce P. Fairclough, PharmD

    • Senior Manager, Medical Information Services
    • Sanofi, United States

  • Tim  Fish

    Tim Fish

    • Director, Global Medical Information
    • Sarepta Therapeutics, Inc., United States

  • Ryan Thomas Hietpas

    Ryan Thomas Hietpas

    • Consultant, Global Scientific Communications
    • Eli Lilly and Company, United States

  • Cynthia Louise Hooper, MA

    Cynthia Louise Hooper, MA

    • Senior Scientific Communications Associate
    • Eli Lilly & Company, United States

  • Hiren  Patel, PharmD, RPh

    Hiren Patel, PharmD, RPh

    • Director, Medical Information
    • Sunovion Pharmaceuticals Inc., United States

  • Tanya  Basu, JD, PharmD

    Tanya Basu, JD, PharmD

    • Director, Medical Communications
    • Shire, United States

  • Randy  Miller

    Randy Miller

    • National Director, Medical Science Liaisons
    • Alnylam Pharmaceuticals, United States

  • Carri  Taylor, MBA

    Carri Taylor, MBA

    • Associate Director, Medical Writing
    • inVentiv Health Clinical, United States

  • Tatyana  Wanderer, PhD

    Tatyana Wanderer, PhD

    • Director, Strategic Partnership Alliances; Principal Regulatory Writer
    • Synchrogenix, a Certara Company, United States

    During her 10-year career as a clinical regulatory writer, Dr. Wanderer has authored and coordinated high quality production of a variety of ICH-compliant regulatory documents in the US and Asia. She leverages her leadership and project management skills, advising clients and managing writers and projects. As a Director of Strategic Partnership Alliances Dr. Wanderer coordinates large-scale collaboration with CISCRP on plain language writing.

  • Rebecca J. Williams, PharmD, MPH

    Rebecca J. Williams, PharmD, MPH

    • Assistant Director,, NCBI
    • National Library of Medicine, NIH, United States

    Rebecca Williams, PharmD, MPH, is Assistant Director, at the National Library of Medicine, National Institutes of Health. In this role, she oversees the results submission process, outreach and education, policy development, and conducts research. Her prior experience was in the area of prescription drug advertising and promotion at FDA and then as a consultant. She received her Pharm.D. from the University of Wisconsin-Madison and MPH from Johns Hopkins University.